Aurinia Pharmaceuticals (AUPH)
(Delayed Data from NSDQ)
$5.88 USD
+0.26 (4.63%)
Updated Jul 31, 2024 04:00 PM ET
After-Market: $5.88 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | 0.01 |
EPS Last Quarter | -0.03 |
Last EPS Surprise | 82.35% |
ABR | 1.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.04 |
Next Year | 0.53 |
EPS (TTM) | -0.39 |
P/E (F1) | 132.24 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 54.89M | 55.64M | 230.74M | 291.87M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 58.44M | 57.40M | 236.90M | 318.46M |
Low Estimate | 51.53M | 52.90M | 220.20M | 270.40M |
Year ago Sales | 41.49M | 54.52M | 175.51M | 230.74M |
Year over Year Growth Est. | 32.30% | 2.05% | 31.46% | 26.49% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.01 | 0.04 | 0.04 | 0.53 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | 0.01 | 0.04 | -0.04 | 0.80 |
High Estimate | 0.01 | 0.05 | 0.16 | 0.80 |
Low Estimate | 0.00 | 0.03 | -0.20 | 0.23 |
Year ago EPS | -0.08 | -0.09 | -0.54 | 0.04 |
Year over Year Growth Est. | 112.50% | 144.44% | 107.41% | 1,218.75% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.01 | 0.04 | 0.04 | 0.53 |
7 Days Ago | 0.01 | 0.04 | 0.04 | 0.53 |
30 Days Ago | 0.01 | 0.04 | 0.04 | 0.53 |
60 Days Ago | 0.01 | 0.04 | 0.04 | 0.53 |
90 Days Ago | -0.02 | 0.01 | -0.12 | 0.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.01 | 0.04 | 0.04 | 0.53 |
Zacks Consensus Estimate | 0.01 | 0.04 | 0.04 | 0.53 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.03 | -0.19 | -0.09 | -0.08 | NA |
Estimate | -0.17 | -0.18 | -0.17 | -0.20 | NA |
Difference | 0.14 | -0.01 | 0.08 | 0.12 | 0.08 |
Surprise | 82.35% | -5.56% | 47.06% | 60.00% | 45.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more